TNXP GlobeNewswire a day ago Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 📊 AI Sentiment Positive 7/10
TNXP Zacks Small Cap Research 2 days ago OTC Markets Hosts Virtual Investor Presentation with Dr. Seth Lederman, Co-Founder, CEO, and Chairman of Tonix Pharmaceuticals, and David Bautz, PhD, Senior Analyst at Zacks SCR
TNXP GlobeNewswire 5 days ago Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
TNXP GlobeNewswire 6 days ago Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
